Participant flow

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer · Source last updated 2019-07-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Paclitaxel 135 mg/m2 IV over 24 hrs on day 1 Cisplatin 50 mg/m2 IV on day 2 OR Paclitaxel 175 mg/m2 IV over 3 hrs on day 1 Cisplatin 50 mg/m2 IV on day 2 OR Paclitaxel 175 mg/m2 IV over 3 hrs on day 1 Cisplatin 50 mg/m2 IV on day 1 Cycles repeated q21 days to progression/toxicity

   id

   FG000

   title

   Arm I (Paclitaxel and Cisplatin)

2. description

   Paclitaxel 135 mg/m2 IV over 24 hrs on day 1 Cisplatin 50 mg/m2 IV on day 2 Bevacizumab 15 mg/kg IV day 2 OR Paclitaxel 175 mg/m2 IV over 3 hrs on day 1 Cisplatin 50 mg/m2 IV on day 2 Bevacizumab 15 mg/kg IV day 2 OR Paclitaxel 175 mg/m2 IV over 3 hrs on day 1 Cisplatin 50 mg/m2 IV on day 1 Bevacizumab 15 mg/kg IV day 1 Cycles repeated q21 days to progression/toxicity

   id

   FG001

   title

   Arm II (Paclitaxel, Cisplatin, Bevacizumab)

3. description

   Paclitaxel 175 mg/m2 over 3 hrs on day 1 Topotecan 0.75 mg/m2 over 30 mins days 1-3 Cycles repeated q21 days to progression/toxicity

   id

   FG002

   title

   Arm III (Topotecan Hydrochloride and Paclitaxel)

4. description

   Paclitaxel 175 mg/m2 over 3 hrs on day 1 Topotecan 0.75 mg/m2 over 30 mins days 1-3 Bevacizumab 15 mg/kg IV day 1 Cycles repeated q21 days to progression/toxicity

   id

   FG003

   title

   Arm IV (Topotecan Hydrochloride, Paclitaxel, Bevacizumab)

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         114

      2. group Id

         FG001

         num Subjects

         115

      3. group Id

         FG002

         num Subjects

         111

      4. group Id

         FG003

         num Subjects

         112

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         114

      2. group Id

         FG001

         num Subjects

         115

      3. group Id

         FG002

         num Subjects

         111

      4. group Id

         FG003

         num Subjects

         112

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

recruitment Details

The study was activated on 4/6/2009 and closed to accrual on 1/3/2012.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice